talazoparib
pfizer
['prostate', 'talapro-3', 'tps5096', 'pfizer']
the design of the ongoing phase 3 talapro-3 study, evaluating efficacy &amp; safety of a parpi + an androgen receptor inhibitor (ari) vs ari monotherapy in pts w/ ddrm metastatic castration-sensitive #prostatecancer, is being presented at #asco22 tps5096 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ